What drugs are not recommended to be infused in dextrose (intravenous) IV?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drugs Not Recommended for Infusion in Dextrose IV

Several medications should not be infused in dextrose-containing solutions due to physical incompatibility, chemical degradation, or reduced efficacy. Based on the available evidence, these incompatibilities can lead to precipitation, reduced drug effectiveness, or potential patient harm 1, 2.

Key Incompatible Drug Categories

Antibiotics

  • Cephalosporins including cefazolin, cefepime, ceftaroline fosamil, ceftazidime, ceftriaxone, and cefuroxime should not be administered in dextrose solutions 2
  • Penicillins including ampicillin-sulbactam, piperacillin-tazobactam (in 5% dextrose only), and penicillin G potassium (in 5% dextrose only) are incompatible with dextrose solutions 3, 2
  • Other antimicrobials including azithromycin (in 5% dextrose only), colistimethate sodium, and tedizolid should be avoided in dextrose solutions 2

Antifungals

  • Amphotericin B (all formulations: deoxycholate, lipid complex, and liposome) is incompatible with dextrose solutions 2
  • Micafungin should not be administered in dextrose solutions 2

Cardiovascular Drugs

  • Amiodarone shows significant sorption to PVC infusion bags when prepared in dextrose solutions, with up to 40% loss of drug concentration after 120 hours 4
  • Furosemide is physically incompatible with dextrose solutions 2

Other Critical Medications

  • Propofol forms an unstable emulsion when mixed with dextrose solutions 2, 5
  • Phenytoin and fosphenytoin precipitate in dextrose solutions 2, 6
  • Sodium bicarbonate and phosphate solutions (both sodium and potassium) are incompatible with dextrose 2
  • Methylprednisolone should not be administered in dextrose solutions 2

Clinical Implications and Recommendations

Prevention Strategies

  • When multiple IV medications are required, consider using a multilumen infusion device like Edelvaiss Multiline-8, which has been shown to prevent physical drug incompatibilities in 49% of tested drug combinations 7
  • For drugs requiring dextrose-free administration, use normal saline (0.9% sodium chloride) or other compatible solutions as specified in the drug's administration guidelines 1, 2

Special Considerations for Specific Medications

  • For iron preparations (iron dextran, ferric sodium gluconate), administration in normal saline is preferred over dextrose solutions 1
  • When administering vasoactive drugs like epinephrine, norepinephrine, or phenylephrine, avoid mixing with dextrose if possible, as these critical medications should be administered through dedicated lines 1

Alternative Solutions

  • When balanced electrolytes are needed without dextrose, consider PlasmaLyte, which contains no glucose but provides electrolytes that closely mimic human plasma 8
  • For patients requiring both balanced electrolytes and dextrose, consider separate administration of PlasmaLyte and dextrose solution, or choose alternative solutions 8

Common Pitfalls to Avoid

  • Never mix incompatible drugs in the same IV line or solution, even temporarily, as precipitation can occur immediately 2, 5
  • Be aware that some incompatibilities are not immediately visible - precipitation or degradation may occur over time 4
  • Remember that Y-site administration (where two separate IV lines meet near the patient) can still result in drug incompatibilities if the medications are not compatible 2, 5
  • Always check compatibility charts or consult with a pharmacist when uncertain about specific drug-solution compatibility 1, 2

By understanding these incompatibilities and following appropriate administration guidelines, clinicians can prevent potential adverse events related to inappropriate IV drug administration in dextrose solutions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017

Research

Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Guideline

PlasmaLyte Composition and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.